Sté Tunisienne des Maladies Respiratoires et d'Allergologie
Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis
![[Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease](/media/k2/items/cache/b7776ccd86677e084c73066d56234a62_L.jpg)
[Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease
Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial – medRxiv
The post [Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease appeared first on Links Medicus.
-
Taille de police
Réduire la taille de la police
Augmenter la taille de police
About Author
Dernier de Zouhair Souissi
- M-A | Catheter-directed thrombolysis vs. systemic thrombolysis and anticoagulation in intermediate- or high-risk pulmonary embolism
- AHA Scientific Statement | Pulmonary hypertension in congenital heart disease
- RCT | Cytisinicline shows significant efficacy in smoking cessation over placebo
- M-A | Adjunctive corticosteroids improve survival, clinical outcomes in severe community-acquired pneumonia
- M-A | Drug therapies for treatment of idiopathic pulmonary fibrosis
Laissez un commentaire
Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.